ATTR amyloidosis has a higher cardiac device implantation rate than AL amyloidosis, but AL amyloidosis is linked to higher in-hospital mortality after device implantation.
What is the utilization rate and in-hospital mortality of cardiac device implantation in patients with AL versus ATTR amyloidosis?
While cardiac devices are implanted more frequently in ATTR amyloidosis, patients with AL amyloidosis face higher in-hospital mortality following pacemaker or ICD implantation.
Tasa de eventos absoluta: 0% vs 0%
ATTR-AMD has a higher CDI rate as compared to AL-AMD. Underlying AL-AMD is associated with higher in-hospital mortality in patients undergoing PP and ICD implantation.
Hussain et al. (Wed,) reported a other. ATTR amyloidosis has a higher cardiac device implantation rate than AL amyloidosis, but AL amyloidosis is linked to higher in-hospital mortality after device implantation.